Hub : Traits :

Current tobacco smoking

46 significantly associated models · 31 unique genes.

Significant Loci

# chr p0 p1 # assoc genes # joint genes best TWAS P best SNP P cond SNP P % var exp joint genes
1 7 116660803 118207833 1 1 6.4e-08 2.1e-08 5.4e-02 88 CTTNBP2
2 8 91282507 92689456 1 1 1.8e-07 2.3e-06 1.8e-03 56 RP11-122A3.2
3 9 126927285 129422783 9 2 2.8e-10 2.7e-08 9.1e-01 100 MAPKAP1 PRPS1P2
4 9 135521303 136922700 1 1 7.5e-09 1.7e-23 7.5e-19 21 SURF1
5 10 103550604 105694301 6 1 7.7e-09 1.1e-07 8.4e-02 89 RP11-332O19.5
6 11 16709350 18106069 1 1 4.0e-07 2.2e-07 2.6e-02 82 KCNJ11
7 12 120242845 121660787 1 1 2.3e-07 1.6e-04 5.1e-01 97 COQ5
8 14 103483881 105007585 2 1 6.7e-08 5.7e-07 6.2e-02 86 PPP1R13B
9 15 46780520 48764942 1 1 4.1e-08 6.1e-08 4.5e-04 58 SEMA6D
10 20 61576647 62912463 4 1 6.0e-08 7.3e-08 1.0e+00 100 ARFRP1
11 22 41181586 42907619 4 1 2.7e-08 3.3e-08 1.0e-02 78 MEI1

Pleiotropic Associations

Trait chisq ratio # genes+ # genes++ % genes++ corr corr P genes
Crohns Disease (2017) 3.19 2 1 3.0 0.00 1.0e+00 ARFRP1 MEI1
Irritable Bowel Disease (IBD) 3.58 2 1 3.0 0.00 1.0e+00 ARFRP1 KCNJ11
Ulcerative Colitis (UC) 2.47 2 1 3.0 0.00 1.0e+00 ARFRP1 KCNJ11
Major Depression (MDD) 3.79 1 0 0.0 0.00 1.0e+00 CTTNBP2
Verbal and Numeric Reasoning (VNR) 1.57 2 0 0.0 0.00 1.0e+00 MEI1 PPP1R13B
Prostate Cancer 3.74 1 1 3.0 0.00 1.0e+00 ARFRP1
Crohns Disease (2012) 3.04 1 1 3.0 0.00 1.0e+00 ARFRP1
Schizophrenia 2.55 3 0 0.0 0.00 1.0e+00 KCNJ11 PPP1R13B RP11-332O19.5
Ulcerative Colitis 2.58 2 1 3.0 0.00 1.0e+00 ARFRP1 KCNJ11
Blood Eosinophil Count 1.56 5 1 3.0 -0.12 8.5e-01 ARFRP1 KCNJ11 MEI1 PPP1R13B SURF1
Blood Platelet Count 1.15 4 2 6.1 -0.97 3.3e-02 ARFRP1 KCNJ11 MEI1 RP11-332O19.5
Blood Red Count 0.99 4 3 9.1 -1.00 5.1e-04 ARFRP1 MAPKAP1 PPP1R13B SURF1
Blood White Count 2.10 5 3 9.1 -0.98 3.8e-03 ARFRP1 PPP1R13B RP11-332O19.5 SEMA6D SURF1
Heel T-Score 1.22 2 1 3.0 0.00 1.0e+00 ARFRP1 PPP1R13B
BMI 1.82 5 1 3.0 -0.56 3.3e-01 ARFRP1 MAPKAP1 MEI1 PPP1R13B RP11-122A3.2
Height 2.24 11 6 18.2 0.44 1.8e-01 ARFRP1 COQ5 CTTNBP2 KCNJ11 MAPKAP1 MEI1 PPP1R13B PRPS1P2 RP11-122A3.2 RP11-332O19.5 SURF1
Waist Hip Ratio (WHR) 1.69 3 0 0.0 0.00 1.0e+00 MAPKAP1 PRPS1P2 SEMA6D
Systolic Blood Pressure 2.92 4 2 6.1 0.98 2.5e-02 COQ5 KCNJ11 MAPKAP1 RP11-122A3.2
Smoking Status 17.10 12 8 24.2 -0.97 1.5e-07 ARFRP1 COQ5 CTTNBP2 KCNJ11 MAPKAP1 MEI1 PPP1R13B PRPS1P2 RP11-122A3.2 RP11-332O19.5 SEMA6D SURF1
Allergy or Eczema 3.01 3 2 6.1 0.00 1.0e+00 ARFRP1 MEI1 RP11-332O19.5
Cardiovascular Disease 1.75 2 0 0.0 0.00 1.0e+00 KCNJ11 MAPKAP1
Hypothyroidism (self reported) 1.73 2 0 0.0 0.00 1.0e+00 KCNJ11 MEI1
Respiratory disease 3.04 2 1 3.0 0.00 1.0e+00 ARFRP1 MEI1
Type 2 Diabetes (T2D) 2.89 3 0 0.0 0.00 1.0e+00 ARFRP1 CTTNBP2 KCNJ11
Lung FEV1/FVC ratio 1.16 3 0 0.0 0.00 1.0e+00 CTTNBP2 MEI1 RP11-332O19.5
Lung FVC 3.35 4 1 3.0 0.88 1.2e-01 ARFRP1 CTTNBP2 MEI1 PRPS1P2
Neuroticism 2.23 3 0 0.0 0.00 1.0e+00 CTTNBP2 MEI1 PRPS1P2
Chronotype (morning person) 1.56 1 0 0.0 0.00 1.0e+00 MEI1
Hair Pigment 0.23 3 1 3.0 0.00 1.0e+00 ARFRP1 MEI1 PPP1R13B
Tanning 0.43 2 0 0.0 0.00 1.0e+00 MAPKAP1 RP11-332O19.5
Hand grip strength (left) 2.79 3 1 3.0 0.00 1.0e+00 MAPKAP1 PRPS1P2 RP11-332O19.5
Average weekly spirits intake 1.64 1 0 0.0 0.00 1.0e+00 MEI1
Sensitivity / hurt feelings 2.48 2 0 0.0 0.00 1.0e+00 MAPKAP1 PRPS1P2
Systolic blood pressure, automated reading 2.20 2 0 0.0 0.00 1.0e+00 KCNJ11 MAPKAP1
Vitamin and mineral supplements 1.51 1 0 0.0 0.00 1.0e+00 RP11-332O19.5
Diabetes (mother) 2.39 1 0 0.0 0.00 1.0e+00 COQ5
Pack years adult smoking proportion 5.68 5 0 0.0 0.99 6.1e-04 MAPKAP1 PPP1R13B PRPS1P2 SEMA6D SURF1
Impedance of leg (right) 1.48 4 0 0.0 0.42 5.8e-01 KCNJ11 PPP1R13B PRPS1P2 SEMA6D
Leg fat-free mass (left) 1.29 3 0 0.0 0.00 1.0e+00 PRPS1P2 RP11-332O19.5 SEMA6D
Trunk fat percentage 2.56 4 2 6.1 -0.43 5.7e-01 ARFRP1 MEI1 RP11-122A3.2 SEMA6D
Hand grip strength (right) 2.99 3 2 6.1 0.00 1.0e+00 MAPKAP1 PRPS1P2 RP11-332O19.5
Townsend deprivation index at recruitment 4.43 3 0 0.0 0.00 1.0e+00 CTTNBP2 MAPKAP1 PRPS1P2
Maternal smoking around birth 5.76 4 0 0.0 0.99 1.5e-02 MEI1 PPP1R13B RP11-332O19.5 SURF1
Fed-up feelings 2.29 2 0 0.0 0.00 1.0e+00 CTTNBP2 MEI1
Frequency of unenthusiasm / disinterest in last 2 weeks 2.72 1 0 0.0 0.00 1.0e+00 CTTNBP2
Age when periods started (menarche) 1.41 1 0 0.0 0.00 1.0e+00 PRPS1P2
High blood pressure 1.27 2 0 0.0 0.00 1.0e+00 KCNJ11 MAPKAP1
Hayfever, allergic rhinitis or eczema 2.49 3 0 0.0 0.00 1.0e+00 ARFRP1 MEI1 RP11-332O19.5
Medication: Levothyroxine sodium 1.20 1 0 0.0 0.00 1.0e+00 MEI1
Sitting height 1.36 6 0 0.0 -0.50 3.1e-01 KCNJ11 MAPKAP1 PRPS1P2 RP11-122A3.2 RP11-332O19.5 SURF1
Body mass index (BMI) 1.88 4 0 0.0 0.64 3.6e-01 ARFRP1 PPP1R13B RP11-122A3.2 SEMA6D
Impedance of leg (left) 1.55 5 0 0.0 0.46 4.4e-01 ARFRP1 KCNJ11 PPP1R13B PRPS1P2 SEMA6D
Leg predicted mass (left) 1.29 3 0 0.0 0.00 1.0e+00 PRPS1P2 RP11-332O19.5 SEMA6D
Trunk fat mass 2.18 3 2 6.1 0.00 1.0e+00 ARFRP1 MEI1 SEMA6D
Waist circumference 2.20 5 1 3.0 0.99 1.8e-03 ARFRP1 MAPKAP1 PPP1R13B RP11-122A3.2 RP11-332O19.5
Number of incorrect matches in round 2.10 1 0 0.0 0.00 1.0e+00 RP11-332O19.5
Past tobacco smoking 6.77 4 2 6.1 -0.97 3.0e-02 CTTNBP2 MAPKAP1 PRPS1P2 RP11-332O19.5
Alcohol usually taken with meals 3.54 2 0 0.0 0.00 1.0e+00 CTTNBP2 SEMA6D
Nervous feelings 2.02 2 0 0.0 0.00 1.0e+00 PRPS1P2 RP11-332O19.5
Forced vital capacity (FVC) 2.95 3 2 6.1 0.00 1.0e+00 ARFRP1 PRPS1P2 RP11-332O19.5
Qualifications: None of the above 2.22 1 0 0.0 0.00 1.0e+00 SEMA6D
Financial difficulties in last 2 years 4.24 1 0 0.0 0.00 1.0e+00 PPP1R13B
Mouth/teeth dental problems 2.40 1 0 0.0 0.00 1.0e+00 PRPS1P2
Allergy 2.95 3 2 6.1 0.00 1.0e+00 ARFRP1 MEI1 RP11-332O19.5
Pain all over the body in last month 3.08 1 0 0.0 0.00 1.0e+00 ARFRP1
Diabetes (self-reported) 2.43 1 0 0.0 0.00 1.0e+00 KCNJ11
Fluid intelligence score 1.82 2 0 0.0 0.00 1.0e+00 KCNJ11 PPP1R13B
Neuroticism score 2.08 3 0 0.0 0.00 1.0e+00 CTTNBP2 MEI1 PRPS1P2
Weight 1.65 3 1 3.0 0.00 1.0e+00 ARFRP1 MEI1 RP11-332O19.5
Impedance of arm (right) 1.43 3 0 0.0 0.00 1.0e+00 KCNJ11 MEI1 RP11-332O19.5
Arm fat percentage (right) 2.64 6 0 0.0 0.19 7.2e-01 ARFRP1 MAPKAP1 MEI1 PPP1R13B RP11-122A3.2 SEMA6D
Trunk fat-free mass 1.38 3 2 6.1 0.00 1.0e+00 MAPKAP1 PRPS1P2 RP11-332O19.5
Hip circumference 2.02 6 1 3.0 0.24 6.5e-01 ARFRP1 MEI1 PPP1R13B RP11-122A3.2 RP11-332O19.5 SEMA6D
Alcohol intake versus 10 years previously 2.09 2 0 0.0 0.00 1.0e+00 CTTNBP2 RP11-332O19.5
Worrier / anxious feelings 2.75 2 1 3.0 0.00 1.0e+00 MEI1 RP11-332O19.5
Frequency of tiredness / lethargy in last 2 weeks 2.69 3 0 0.0 0.00 1.0e+00 MEI1 PPP1R13B PRPS1P2
Forced expiratory volume in 1-second (FEV1) 3.26 4 2 6.1 -0.22 7.8e-01 ARFRP1 CTTNBP2 PRPS1P2 RP11-332O19.5
Pulse rate 2.44 1 0 0.0 0.00 1.0e+00 MAPKAP1
Qualifications: A levels/AS levels or equivalent 2.14 2 0 0.0 0.00 1.0e+00 CTTNBP2 SEMA6D
Mouth/teeth dental problems: Dentures 3.35 1 0 0.0 0.00 1.0e+00 KCNJ11
Asthma 1.92 2 0 0.0 0.00 1.0e+00 ARFRP1 MEI1
Forced expiratory volume in 1-second (FEV1), Best measure 2.43 3 1 3.0 0.00 1.0e+00 ARFRP1 PRPS1P2 RP11-332O19.5
Impedance of arm (left) 1.57 3 0 0.0 0.00 1.0e+00 KCNJ11 MEI1 RP11-332O19.5
Arm fat mass (right) 2.17 5 0 0.0 0.14 8.2e-01 ARFRP1 MEI1 PPP1R13B RP11-122A3.2 SEMA6D
Trunk predicted mass 1.39 3 2 6.1 0.00 1.0e+00 MAPKAP1 PRPS1P2 RP11-332O19.5
Standing height 2.00 7 4 12.1 -0.63 1.3e-01 COQ5 KCNJ11 MAPKAP1 MEI1 PRPS1P2 RP11-122A3.2 RP11-332O19.5
Tense / 'highly strung' 1.82 1 0 0.0 0.00 1.0e+00 MEI1
Seen doctor (GP) for nerves, anxiety, tension or depression 3.00 2 0 0.0 0.00 1.0e+00 CTTNBP2 PRPS1P2
Peak expiratory flow (PEF) 3.17 3 2 6.1 0.00 1.0e+00 CTTNBP2 PRPS1P2 RP11-332O19.5
Pulse wave reflection index 2.86 1 0 0.0 0.00 1.0e+00 MAPKAP1
Medication for cholesterol, blood pressure or diabetes 1.00 1 0 0.0 0.00 1.0e+00 MAPKAP1
Hypothyroidism/myxoedema (self-reported) 1.26 1 0 0.0 0.00 1.0e+00 MEI1
Medication: Amlodipine 2.15 1 0 0.0 0.00 1.0e+00 MAPKAP1
Forced vital capacity (FVC), Best measure 2.18 3 1 3.0 0.00 1.0e+00 ARFRP1 PRPS1P2 RP11-332O19.5
Body fat percentage 2.66 5 2 6.1 -0.30 6.2e-01 ARFRP1 MAPKAP1 MEI1 RP11-122A3.2 SEMA6D
Leg fat percentage (right) 2.52 4 1 3.0 0.76 2.4e-01 ARFRP1 MAPKAP1 MEI1 RP11-122A3.2
Arm fat-free mass (right) 1.26 2 1 3.0 0.00 1.0e+00 PRPS1P2 RP11-332O19.5
Exposure to tobacco smoke outside home 4.69 2 1 3.0 0.00 1.0e+00 CTTNBP2 RP11-332O19.5
Worry too long after embarrassment 1.84 2 0 0.0 0.00 1.0e+00 CTTNBP2 PRPS1P2
Seen a psychiatrist for nerves, anxiety, tension or depression 2.60 2 0 0.0 0.00 1.0e+00 CTTNBP2 PRPS1P2
Wheeze or whistling in the chest in last year 3.22 1 1 3.0 0.00 1.0e+00 ARFRP1
Age at first live birth 1.96 1 0 0.0 0.00 1.0e+00 CTTNBP2
Qualifications: College or University degree 2.98 5 1 3.0 -0.98 2.4e-03 ARFRP1 CTTNBP2 PRPS1P2 RP11-122A3.2 SEMA6D
Medication for pain relief, constipation, heartburn 1.73 1 0 0.0 0.00 1.0e+00 PRPS1P2
Medication: Blood pressure 1.11 1 0 0.0 0.00 1.0e+00 MAPKAP1
Mean time to correctly identify matches 1.85 1 0 0.0 0.00 1.0e+00 MEI1
Whole body fat mass 2.28 5 1 3.0 -0.28 6.5e-01 ARFRP1 MEI1 RP11-122A3.2 RP11-332O19.5 SEMA6D
Leg fat mass (right) 2.15 4 1 3.0 0.62 3.8e-01 ARFRP1 MEI1 RP11-122A3.2 RP11-332O19.5
Arm predicted mass (right) 1.31 2 1 3.0 0.00 1.0e+00 PRPS1P2 RP11-332O19.5
Pulse rate, automated reading 4.06 3 1 3.0 0.00 1.0e+00 ARFRP1 MAPKAP1 RP11-122A3.2
Alcohol intake frequency. 1.84 1 0 0.0 0.00 1.0e+00 MEI1
Comparative height size at age 10 2.14 4 2 6.1 -0.71 2.9e-01 COQ5 KCNJ11 MAPKAP1 RP11-332O19.5
Overall health rating 2.85 2 0 0.0 0.00 1.0e+00 MAPKAP1 PRPS1P2
Commuting to job workplace: Car/motor vehicle 1.96 1 0 0.0 0.00 1.0e+00 RP11-122A3.2
Illness, injury, bereavement, stress in last 2 years 2.38 1 0 0.0 0.00 1.0e+00 CTTNBP2
Hypertension (Self-reported) 1.26 2 0 0.0 0.00 1.0e+00 KCNJ11 MAPKAP1
Smoking status: Previous 3.10 1 0 0.0 0.00 1.0e+00 RP11-332O19.5
Forced expiratory volume in 1-second (FEV1), predicted 1.66 1 0 0.0 0.00 1.0e+00 RP11-332O19.5
Whole body fat-free mass 1.28 2 2 6.1 0.00 1.0e+00 PRPS1P2 RP11-332O19.5
Leg fat-free mass (right) 1.25 2 0 0.0 0.00 1.0e+00 PRPS1P2 RP11-332O19.5
Arm fat percentage (left) 2.57 6 1 3.0 0.14 7.9e-01 ARFRP1 MAPKAP1 MEI1 PPP1R13B RP11-122A3.2 SEMA6D
Handedness (chirality/laterality): Left-handed 1.17 1 0 0.0 0.00 1.0e+00 SEMA6D
Mood swings 2.46 2 0 0.0 0.00 1.0e+00 CTTNBP2 MEI1
Long-standing illness, disability or infirmity 2.74 1 0 0.0 0.00 1.0e+00 ARFRP1
Ever had bowel cancer screening 2.62 1 0 0.0 0.00 1.0e+00 SURF1
Diabetes diagnosed by doctor 2.46 1 0 0.0 0.00 1.0e+00 KCNJ11
Asthma (self-reported) 2.02 2 0 0.0 0.00 1.0e+00 ARFRP1 MEI1
Osteoarthritis (self-reported) 2.47 1 0 0.0 0.00 1.0e+00 MAPKAP1
Medication: Gliclazide 2.16 1 0 0.0 0.00 1.0e+00 KCNJ11
Smoking status: Current 17.12 12 7 21.2 1.00 6.8e-15 ARFRP1 COQ5 CTTNBP2 KCNJ11 MAPKAP1 MEI1 PPP1R13B PRPS1P2 RP11-122A3.2 RP11-332O19.5 SEMA6D SURF1
Forced expiratory volume in 1-second (FEV1), predicted percentage 2.94 2 1 3.0 0.00 1.0e+00 ARFRP1 PRPS1P2
Whole body water mass 1.29 2 2 6.1 0.00 1.0e+00 PRPS1P2 RP11-332O19.5
Leg predicted mass (right) 1.24 3 0 0.0 0.00 1.0e+00 PRPS1P2 RP11-332O19.5 SEMA6D
Arm fat mass (left) 2.07 5 0 0.0 0.11 8.5e-01 ARFRP1 MEI1 PPP1R13B RP11-122A3.2 SEMA6D
Number of self-reported non-cancer illnesses 2.40 2 0 0.0 0.00 1.0e+00 ARFRP1 MEI1
Miserableness 1.74 1 0 0.0 0.00 1.0e+00 CTTNBP2
Mother's age at death 2.78 1 0 0.0 0.00 1.0e+00 MAPKAP1
Financial situation satisfaction 3.27 1 0 0.0 0.00 1.0e+00 KCNJ11
Medication: Blood pressure 1.43 1 0 0.0 0.00 1.0e+00 KCNJ11
High cholesterol (Self-reported) 1.48 1 0 0.0 0.00 1.0e+00 SURF1
Ever smoked 8.01 4 3 9.1 0.99 1.3e-02 CTTNBP2 KCNJ11 PRPS1P2 RP11-332O19.5
Basal metabolic rate 1.30 2 1 3.0 0.00 1.0e+00 PRPS1P2 RP11-332O19.5
Leg fat percentage (left) 2.82 4 2 6.1 0.78 2.2e-01 ARFRP1 MAPKAP1 MEI1 RP11-122A3.2
Arm fat-free mass (left) 1.36 2 1 3.0 0.00 1.0e+00 PRPS1P2 RP11-332O19.5
Irritability 2.01 1 0 0.0 0.00 1.0e+00 MEI1
Risk taking 2.63 1 0 0.0 0.00 1.0e+00 PPP1R13B
Fractured/broken bones in last 5 years 2.05 1 0 0.0 0.00 1.0e+00 CTTNBP2
Diastolic blood pressure, automated reading 1.97 2 0 0.0 0.00 1.0e+00 ARFRP1 MAPKAP1
Vascular/heart problems diagnosed by doctor 1.05 1 0 0.0 0.00 1.0e+00 MAPKAP1
Cholesterol lowering medication 1.44 1 0 0.0 0.00 1.0e+00 SURF1
Medication: Omeprazole (e.g. Zanprol) 2.93 2 0 0.0 0.00 1.0e+00 ARFRP1 KCNJ11
Pain experienced in last month 2.29 1 0 0.0 0.00 1.0e+00 PRPS1P2
Pack years of smoking 5.06 3 0 0.0 0.00 1.0e+00 PPP1R13B SEMA6D SURF1
Impedance of whole body 1.51 4 0 0.0 0.94 6.0e-02 KCNJ11 MEI1 PPP1R13B PRPS1P2
Leg fat mass (left) 2.29 4 1 3.0 0.64 3.6e-01 ARFRP1 MEI1 RP11-122A3.2 RP11-332O19.5
Arm predicted mass (left) 1.34 2 1 3.0 0.00 1.0e+00 PRPS1P2 RP11-332O19.5

Associations by panel

study tissue # hits % hits/tests avg chisq
GTEx Adipose Subcutaneous 1 0.0286 1.72
GTEx Adipose Visceral Omentum 1 0.0491 1.73
GTEx Adrenal Gland 0 0.0000 1.69
GTEx Artery Aorta 1 0.0336 1.66
GTEx Artery Coronary 1 0.0845 1.64
GTEx Artery Tibial 2 0.0532 1.63
GTEx Brain Caudate basal ganglia 0 0.0000 1.69
GTEx Brain Cerebellar Hemisphere 2 0.1343 1.71
GTEx Brain Cerebellum 2 0.1009 1.66
GTEx Brain Cortex 2 0.1932 1.78
GTEx Brain Frontal Cortex BA9 0 0.0000 1.72
GTEx Brain Hippocampus 0 0.0000 1.57
GTEx Brain Hypothalamus 0 0.0000 1.65
GTEx Brain Nucleus accumbens basal ganglia 0 0.0000 1.65
GTEx Brain Putamen basal ganglia 0 0.0000 1.56
GTEx Breast Mammary Tissue 0 0.0000 1.71
GTEx Breast Mammary Tissue (Male) 1 0.0838 1.63
GTEx Breast Mammary Tissue (Female) 0 0.0000 1.56
GTEx Cells EBV-transformed lymphocytes 1 0.0703 1.64
GTEx Cells Transformed fibroblasts 2 0.0476 1.68
GTEx Colon Sigmoid 0 0.0000 1.75
GTEx Colon Transverse 0 0.0000 1.63
GTEx Esophagus Gastroesophageal Junction 0 0.0000 1.73
GTEx Esophagus Mucosa 0 0.0000 1.64
GTEx Esophagus Muscularis 0 0.0000 1.70
GTEx Heart Atrial Appendage 0 0.0000 1.68
GTEx Heart Left Ventricle 0 0.0000 1.72
GTEx Liver 1 0.1395 1.61
GTEx Lung 0 0.0000 1.62
GTEx Muscle Skeletal 1 0.0346 1.75
GTEx Nerve Tibial 1 0.0231 1.65
GTEx Ovary 1 0.1101 1.59
GTEx Pancreas 0 0.0000 1.76
GTEx Pituitary 0 0.0000 1.64
GTEx Prostate 0 0.0000 1.72
GTEx Skin Not Sun Exposed Suprapubic 1 0.0407 1.68
GTEx Skin Sun Exposed Lower leg 3 0.0824 1.63
GTEx Small Intestine Terminal Ileum 1 0.2169 1.67
GTEx Spleen 1 0.0709 1.65
GTEx Stomach 1 0.0688 1.77
GTEx Testis 1 0.0317 1.66
GTEx Thyroid 3 0.0750 1.67
GTEx Uterus 1 0.1764 1.66
GTEx Vagina 0 0.0000 1.50
GTEx Whole Blood 1 0.0502 1.68
METSIM Adipose 0 0.0000 1.59
NTR Blood 2 0.0833 1.60
ROSMAP Brain Pre-frontal Cortex 2 0.0455 1.65
YFS Blood 2 0.0433 1.56
CommonMind Brain Pre-frontal Cortex 4 0.0744 1.61
TCGA Breast Tumor 1 0.1304 1.59
TCGA Breast Normal 0 0.0000 1.49
TCGA Ovarian Tumor 1 0.0342 1.57
TCGA Prostate Tumor 1 0.0289 1.62